Showing results (61-70 of 1,548) with videos related to

Sort By:
Pageof 155
Contemporary Clinical Trials Communications|February 2, 2019
A randomised controlled trial of potential for pharmacologic prevention of new-onset albuminuria, hypertension and diabetes in a remote Aboriginal Australian community, 2008-2013Wendy E Hoy, Christopher M Reid, Molla Huq, et al.
Contemporary Clinical Trials Communications|December 5, 2019
Pragmatic dose-escalation methods incorporating relative dose intensity assessment for molecularly targeted agents in phase I trialsAkihiro Hirakawa, Yuichi Tanaka, Shuhei Kaneko
Contemporary Clinical Trials Communications|February 20, 2020
Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trialAlkomiet Hasan, Astrid Roeh, Stefan Leucht, et al.
Contemporary Clinical Trials Communications|February 20, 2020
Establishment of optimal exercise therapy using near-infrared spectroscopy monitoring of tissue muscle oxygenation after therapeutic angiogenesis for patients with critical limb ischemia: A multicenter, randomized, controlled trialKeisuke Shoji, Kenji Yanishi, Hirokazu Shiraishi, et al.
Contemporary Clinical Trials Communications|February 27, 2020
Flexible, rule-based dose escalation: The cohort-sequence designShuang Li, Xian-Jin Xie, Daniel F Heitjan
Contemporary Clinical Trials Communications|October 22, 2020
Design, rationale, and baseline characteristics of a pilot randomized clinical trial of nicotine treatment for pulmonary sarcoidosisErinn M Hade, Rachel M Smith, Daniel A Culver, et al.
Contemporary Clinical Trials Communications|September 3, 2020
Theoretical asthma self-management program for Taiwanese adolescents with self-efficacy, outcome-expectancy, health behaviour, and asthma symptoms: A randomized controlled trialTzu-Jung Tseng, Chiung-Jung Jo Wu, Anne M Chang
Contemporary Clinical Trials Communications|September 3, 2020
Design and rationale of FLAVOUR: A phase IIa efficacy study of the 5-lipoxygenase activating protein antagonist AZD5718 in patients with recent myocardial infarctionEva Prescott, John Pernow, Antti Saraste, et al.
Contemporary Clinical Trials Communications|September 3, 2020
Integrative and quantitative bioenergetics: Design of a study to assess the impact of the gut microbiome on host energy balanceKaren D Corbin, Rosa Krajmalnik-Brown, Elvis A Carnero, et al.
Contemporary Clinical Trials Communications|September 5, 2020
A return-to-work intervention protocol directed at cancer patients (self-assessment, tailored information & lifestyle management for returning to work among cancer patients, START): A multi-center, randomized controlled trialKa Ryeong Bae, Danbee Kang, Jae Yoon Yi, et al.
Pageof 155